| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q0X0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.404 |
| CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.482 |
| CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.519 |
| CLV_NRD_NRD_1 | 240 | 242 | PF00675 | 0.430 |
| CLV_PCSK_KEX2_1 | 199 | 201 | PF00082 | 0.500 |
| CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.430 |
| CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.555 |
| CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.438 |
| DOC_MAPK_gen_1 | 152 | 160 | PF00069 | 0.411 |
| DOC_MAPK_gen_1 | 199 | 208 | PF00069 | 0.510 |
| DOC_MAPK_gen_1 | 240 | 246 | PF00069 | 0.527 |
| DOC_MAPK_gen_1 | 274 | 281 | PF00069 | 0.649 |
| DOC_MAPK_gen_1 | 36 | 44 | PF00069 | 0.420 |
| DOC_MAPK_MEF2A_6 | 199 | 208 | PF00069 | 0.510 |
| DOC_PP4_FxxP_1 | 272 | 275 | PF00568 | 0.601 |
| DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.660 |
| DOC_USP7_UBL2_3 | 80 | 84 | PF12436 | 0.446 |
| DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.731 |
| DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.451 |
| LIG_BRCT_BRCA1_1 | 204 | 208 | PF00533 | 0.434 |
| LIG_BRCT_BRCA1_1 | 268 | 272 | PF00533 | 0.432 |
| LIG_BRCT_BRCA1_2 | 204 | 210 | PF00533 | 0.438 |
| LIG_BRCT_BRCA1_2 | 268 | 274 | PF00533 | 0.471 |
| LIG_FHA_1 | 196 | 202 | PF00498 | 0.506 |
| LIG_FHA_1 | 268 | 274 | PF00498 | 0.564 |
| LIG_FHA_1 | 52 | 58 | PF00498 | 0.562 |
| LIG_FHA_1 | 72 | 78 | PF00498 | 0.380 |
| LIG_FHA_2 | 161 | 167 | PF00498 | 0.450 |
| LIG_LIR_Apic_2 | 269 | 275 | PF02991 | 0.497 |
| LIG_LIR_Gen_1 | 145 | 155 | PF02991 | 0.400 |
| LIG_LIR_Gen_1 | 186 | 197 | PF02991 | 0.562 |
| LIG_LIR_Gen_1 | 33 | 42 | PF02991 | 0.519 |
| LIG_LIR_Nem_3 | 137 | 141 | PF02991 | 0.482 |
| LIG_LIR_Nem_3 | 145 | 150 | PF02991 | 0.400 |
| LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.542 |
| LIG_LIR_Nem_3 | 257 | 263 | PF02991 | 0.486 |
| LIG_LIR_Nem_3 | 28 | 34 | PF02991 | 0.491 |
| LIG_PALB2_WD40_1 | 187 | 195 | PF16756 | 0.489 |
| LIG_Pex14_1 | 277 | 281 | PF04695 | 0.535 |
| LIG_SH2_CRK | 147 | 151 | PF00017 | 0.386 |
| LIG_SH2_CRK | 193 | 197 | PF00017 | 0.489 |
| LIG_SH2_PTP2 | 243 | 246 | PF00017 | 0.516 |
| LIG_SH2_SRC | 183 | 186 | PF00017 | 0.503 |
| LIG_SH2_STAP1 | 189 | 193 | PF00017 | 0.503 |
| LIG_SH2_STAP1 | 222 | 226 | PF00017 | 0.380 |
| LIG_SH2_STAP1 | 53 | 57 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.340 |
| LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.455 |
| LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.360 |
| LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.558 |
| LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.569 |
| LIG_SH3_3 | 59 | 65 | PF00018 | 0.441 |
| LIG_SUMO_SIM_anti_2 | 92 | 98 | PF11976 | 0.407 |
| LIG_TRAF2_1 | 251 | 254 | PF00917 | 0.667 |
| LIG_TRFH_1 | 193 | 197 | PF08558 | 0.398 |
| LIG_WRC_WIRS_1 | 135 | 140 | PF05994 | 0.503 |
| MOD_CK1_1 | 15 | 21 | PF00069 | 0.602 |
| MOD_CK1_1 | 3 | 9 | PF00069 | 0.649 |
| MOD_CK2_1 | 160 | 166 | PF00069 | 0.487 |
| MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.683 |
| MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.670 |
| MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.401 |
| MOD_GSK3_1 | 18 | 25 | PF00069 | 0.481 |
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.719 |
| MOD_GSK3_1 | 263 | 270 | PF00069 | 0.441 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.702 |
| MOD_NEK2_1 | 46 | 51 | PF00069 | 0.417 |
| MOD_NEK2_1 | 71 | 76 | PF00069 | 0.375 |
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.631 |
| MOD_PIKK_1 | 263 | 269 | PF00454 | 0.538 |
| MOD_PK_1 | 202 | 208 | PF00069 | 0.493 |
| MOD_PKB_1 | 200 | 208 | PF00069 | 0.460 |
| MOD_Plk_1 | 202 | 208 | PF00069 | 0.506 |
| MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.731 |
| MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.443 |
| MOD_SUMO_for_1 | 255 | 258 | PF00179 | 0.526 |
| TRG_DiLeu_BaEn_1 | 66 | 71 | PF01217 | 0.384 |
| TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.389 |
| TRG_ENDOCYTIC_2 | 189 | 192 | PF00928 | 0.501 |
| TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.482 |
| TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.293 |
| TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.413 |
| TRG_ER_diArg_1 | 199 | 202 | PF00400 | 0.521 |
| TRG_ER_diArg_1 | 240 | 242 | PF00400 | 0.430 |
| TRG_Pf-PMV_PEXEL_1 | 199 | 203 | PF00026 | 0.519 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P695 | Leptomonas seymouri | 80% | 96% |
| A0A1X0P0E3 | Trypanosomatidae | 70% | 97% |
| A0A3R7MCL3 | Trypanosoma rangeli | 66% | 97% |
| A0A3S7XBK2 | Leishmania donovani | 98% | 100% |
| A4HPW1 | Leishmania braziliensis | 89% | 100% |
| A4IDM3 | Leishmania infantum | 98% | 100% |
| D0A4A9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 69% | 94% |
| E9ATM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| V5DLL6 | Trypanosoma cruzi | 71% | 97% |